| View |
|
DR-XY14392
|
Sulfacetamide Sodium
|
Sensocet
|
170 mg/mL (17%w/v)
|
Ophthalmic Solution (Eye Drops)
|
-
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
07 February 2019
|
10 September 2024
|
| View |
|
DR-XY14395
|
Polymyxin B Sulfate + Neomycin Sulfate + Dexamethasone
|
Postop
|
1.25mg/ 3.5mg/ 1mg per mL
|
Ophthalmic Suspension (Drops)
|
Antibacterial /Steroidal Anti-inflammatory
|
E.L. Laboratories, Inc.
|
Philippines
|
Renewal
|
17 June 2022
|
01 July 2026
|
| View |
|
DR-XY14429
|
Mannitol
|
Osmofundin
|
20%
|
Solution For I.V. Infusion
|
Osmotic Diuretic Agent
|
B. Braun Medical Industries Sdn. Bhd.
|
Malaysia
|
Renewal
|
24 January 2024
|
14 May 2029
|
| View |
|
DR-XY14535
|
Cefuroxime (as axetil)
|
Zinnat
|
125mg/5mL
|
Granules For Suspension
|
Antibacterial (Cephalosporin)
|
Glaxo Wellcome Operations
|
United Kingdom
|
-
|
12 May 2020
|
03 November 2024
|
| View |
|
DR-XY14582
|
Furosemide
|
Rasitol
|
10mg/mL
|
Solution For Injection (IV)
|
-
|
Yung Shin Pharmaceuticals Ind. Co., Ltd.- Taichung Youth Factory
|
Taiwan
|
-
|
13 September 2019
|
24 June 2024
|
| View |
|
DR-XY14607
|
Alprazolam
|
Xanor
|
500 mcg
|
Tablet
|
-
|
Pfizer Pharmaceuticals LLC
|
Puerto Rico
|
-
|
16 April 2020
|
21 March 2025
|
| View |
|
DR-XY14608
|
Betaxolol (As Hydrochloride)
|
Betoptic S
|
2.5 mg/mL (0.25%)
|
Sterile Ophthalmic Suspension
|
-
|
Alcon-Couvreur NV
|
Belgium
|
-
|
06 April 2021
|
18 April 2026
|
| View |
|
DR-XY14634-L
|
Dextrose
|
None
|
5% w/v
|
Solution For I.V. Infusion
|
-
|
Baxter Healthcare Phils., Inc.
|
Philippines
|
-
|
27 July 2021
|
27 April 2025
|
| View |
|
DR-XY14635-L
|
0.9% Sodium Chloride
|
None
|
900mg per 100mL
|
Solution For Iv Infusion
|
-
|
Baxter Healthcare Philippines, Inc.
|
Philippines
|
-
|
14 October 2019
|
31 August 2024
|
| View |
|
DR-XY14658
|
Lactated Ringer'S Solution
|
None
|
600mg NaCl, 312mg Na Lactate, 40mg KCl, 27mgCaCl3 Dihydrate
|
Solution For Iv Solution
|
-
|
B. Braun Melsungen AG
|
Germany
|
-
|
06 December 2019
|
13 March 2025
|
| View |
|
DR-XY14670
|
5% Dextrose In 0.9% Sodium Chloride
|
None
|
(See Reverse)
|
Solution For Intravenous Infusion
|
-
|
Amherst Parenterals, Inc.
|
Philippines
|
-
|
23 August 2019
|
19 April 2024
|
| View |
|
DR-XY14700
|
Aluminum Hydroxide + Magnesium Hydroxide
|
None
|
225mg/200mg
|
Suspension
|
ANTACID
|
AM-Europharma
Corporation
|
Philippines
|
Automatic Renewal
|
23 February 2022
|
09 July 2027
|
| View |
|
DR-XY147010
|
Cotrimoxazole
|
Triphimox
|
960 mg
|
Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
27 August 2020
|
27 August 2025
|
| View |
|
DR-XY14710
|
Atenolol/ Chlorthalidone
|
Tenoretic
|
50mg/12.5mg
|
Tablet
|
-
|
AstraZeneca UK Limited
|
United Kingdom
|
Automatic Renewal
|
13 February 2019
|
17 August 2024
|
| View |
|
DR-XY14715
|
Fluorouracil
|
None
|
50 mg/mL (500mg/10mL)
|
Solution For Injection (I.V.)
|
Antineoplastic Agent
|
Hospira Australia Pty. Ltd.
|
Australia
|
Automatic Renewal
|
10 May 2023
|
31 July 2028
|
| View |
|
DR-XY14730
|
Mannitol
|
Unbranded
|
20%
|
Solution For Injection
|
Hyperosmotic Agent
|
Euro-med Laboratories Phil. Inc.
|
Philippines
|
Renewal
|
24 August 2023
|
27 January 2029
|
| View |
|
DR-XY14753
|
Cefazolin Sodium
|
Lupex
|
1g
|
Powder For Injection (Im/Iv)
|
-
|
yung shin pharmaceutial ind. Co., ltd.
|
Taiwan
|
-
|
26 December 2019
|
31 January 2025
|
| View |
|
DR-XY14798
|
Ketorolac Trometamol
|
Toradol
|
30 mg/mL
|
Solution For Injection (Im/Iv)
|
Non-Opioid Analgesic
|
Cenexi
|
France
|
Automatic Renewal
|
13 December 2022
|
23 May 2028
|
| View |
|
DR-XY14835
|
Atenolol
|
Therabloc
|
25 mg
|
Tablet
|
Beta-Adrenoceptor Blocker
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
04 March 2022
|
30 May 2027
|
| View |
|
DR-XY14851
|
Lisinopril
|
Zestril®
|
5 mg
|
Tablet
|
Antihypertensive
|
AstraZeneca Pharmaceutical Co. Ltd.
|
China
|
Renewal
|
01 March 2024
|
24 June 2029
|